MedPath

JEWISH GENERAL HOSPITAL

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
1934-01-01
Employees
-
Market Cap
-
Website
http://www.jgh.ca/

Clinical Trials

94

Active:20
Completed:40

Trial Phases

5 Phases

Phase 1:8
Phase 2:9
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (58 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
31 (53.4%)
Phase 2
9 (15.5%)
Phase 1
8 (13.8%)
Phase 4
7 (12.1%)
Phase 3
3 (5.2%)

The Impact of Fasting Duration on Quality of Recovery After Cesarean Section

Recruiting
Conditions
Quality Improvement
Quality of Recovery From Anaesthesia
Cesarean Section
Fasting ( 6H for Solid ; 2H for Clear Fluid )
First Posted Date
2024-11-22
Last Posted Date
2025-09-04
Lead Sponsor
Jewish General Hospital
Target Recruit Count
100
Registration Number
NCT06701929
Locations
πŸ‡¨πŸ‡¦

Jewish General Hospital, Montreal, Quebec, Canada

Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Not Applicable
Recruiting
Conditions
Pulmonary Thromboembolisms
Hypertension, Pulmonary
First Posted Date
2023-02-09
Last Posted Date
2023-02-09
Lead Sponsor
Jewish General Hospital
Target Recruit Count
40
Registration Number
NCT05719415
Locations
πŸ‡¨πŸ‡¦

David Langleben, Montreal, Quebec, Canada

Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
Prostate Cancer
First Posted Date
2022-08-23
Last Posted Date
2022-08-23
Lead Sponsor
Jewish General Hospital
Target Recruit Count
10
Registration Number
NCT05512663

Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery

Phase 3
Completed
Conditions
Coronary Artery Bypass Graft Surgery
Interventions
Drug: Standard of care
Drug: Parasternal blocks
First Posted Date
2022-01-13
Last Posted Date
2024-06-10
Lead Sponsor
Jewish General Hospital
Target Recruit Count
60
Registration Number
NCT05191745
Locations
πŸ‡¨πŸ‡¦

Jewish General Hospital, Montreal, Quebec, Canada

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Phase 4
Not yet recruiting
Conditions
Left Ventricular Dysfunction
Quality of Recovery
Right Ventricular Dysfunction
Interventions
Drug: Placebo solution
First Posted Date
2022-01-12
Last Posted Date
2025-02-24
Lead Sponsor
Jewish General Hospital
Target Recruit Count
70
Registration Number
NCT05188222
Locations
πŸ‡¨πŸ‡¦

Jewish General Hospital, Montreal, Quebec, Canada

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.